Semler Scientific, Inc. (NASDAQ:SMLR - Get Free Report) was the target of some unusual options trading activity on Wednesday. Investors acquired 2,358 call options on the company. This represents an increase of 96% compared to the average volume of 1,201 call options.
Semler Scientific Trading Down 1.4%
SMLR stock traded down $0.61 during trading on Monday, hitting $44.32. 1,147,120 shares of the company's stock were exchanged, compared to its average volume of 493,030. The business has a 50-day moving average price of $35.99 and a two-hundred day moving average price of $47.22. The stock has a market capitalization of $494.26 million, a price-to-earnings ratio of 9.03 and a beta of 1.33. Semler Scientific has a 52-week low of $21.77 and a 52-week high of $81.56.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its earnings results on Tuesday, May 13th. The company reported ($0.76) EPS for the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The company had revenue of $8.84 million during the quarter.
Institutional Trading of Semler Scientific
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Interchange Capital Partners LLC purchased a new position in Semler Scientific during the 1st quarter worth approximately $46,502,000. Capital International Investors acquired a new position in shares of Semler Scientific in the 4th quarter valued at $30,813,000. Susquehanna Advisors Group Inc. acquired a new position in shares of Semler Scientific in the 4th quarter valued at $26,928,000. Driehaus Capital Management LLC acquired a new stake in Semler Scientific during the 4th quarter worth $10,122,000. Finally, Thames Capital Management LLC purchased a new position in Semler Scientific during the 4th quarter worth $6,465,000. Institutional investors and hedge funds own 49.37% of the company's stock.
Analysts Set New Price Targets
Separately, Wall Street Zen lowered Semler Scientific from a "buy" rating to a "sell" rating in a report on Thursday.
View Our Latest Stock Report on Semler Scientific
About Semler Scientific
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Read More
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
